| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥153.3B | ¥150.9B | +1.6% |
| Operating Income | ¥16.7B | ¥17.9B | -6.8% |
| Ordinary Income | ¥16.9B | ¥18.1B | -6.5% |
| Net Income | ¥11.1B | ¥12.4B | -10.3% |
| ROE | 2.6% | 2.9% | - |
Q1 FY2026 results: Revenue 153.3B yen (YoY +1.6%), Operating Income 16.7B yen (YoY -6.8%), Ordinary Income 16.9B yen (YoY -6.5%), Net Income 11.1B yen (YoY -10.3%). The company achieved modest top-line growth while experiencing profit margin compression. Operating margin declined 1.0pt from 11.9% to 10.9%, driven by SG&A expense increases and profitability deterioration in the Chemical Industry Products Sales segment. Net profit margin decreased 1.0pt from 8.2% to 7.2%. The revenue-up/profit-down pattern reflects structural challenges in cost management and working capital efficiency.
Revenue grew 1.6% YoY to 153.3B yen, with contrasting performance between segments. Chemical Industry Products Sales, representing 70.6% of total revenue, remained essentially flat at +0.1% YoY to 108.2B yen, while Machinery Manufacturing and Sales expanded 5.6% to 45.1B yen. The chemical segment's stagnation suggests market headwinds or pricing pressure in core product lines. Gross profit was maintained at 41.3B yen with margin of 26.9%, essentially unchanged from prior year's 27.5%, indicating stable product mix and raw material cost control. However, SG&A expenses increased 102M yen (+4.3%) to 24.6B yen, rising faster than revenue growth and representing 16.0% of sales versus 15.6% prior year. This expense growth outpaced revenue expansion and contributed to operating income declining 121M yen (-6.8%) to 16.7B yen.
At the segment profit level, Chemical Industry Products Sales experienced significant margin compression with operating income falling 12.9% to 814M yen despite flat revenue, resulting in segment margin of 7.5% versus 8.6% prior year. Machinery Manufacturing and Sales maintained operating income at 858M yen (flat YoY) on higher revenue, improving segment margin to 19.0% from 20.1%. Non-operating items contributed net 17M yen, comprising dividend income 26M yen and foreign exchange losses 9M yen. Extraordinary loss of 7M yen related to disposal of fixed assets had minimal impact. The gap between operating income 16.7B yen and ordinary income 16.9B yen of only 200M yen reflects limited financial leverage and primarily operating-driven profitability. This results in a revenue-up/profit-down scenario, indicating operational efficiency challenges requiring management attention in cost structure and segment profitability recovery.
Chemical Industry Products Sales generated revenue of 108.2B yen (70.6% of total) and operating income of 814M yen with segment margin of 7.5%. This represents the core business but experienced profitability deterioration with operating income declining 12.9% YoY despite revenue remaining essentially flat (+0.1%). The sharp margin compression from 8.6% to 7.5% (-110bp) suggests structural cost pressures or competitive pricing environment in chemical products distribution. Machinery Manufacturing and Sales produced revenue of 45.1B yen (29.4% of total) and operating income of 858M yen, maintaining flat YoY profit on 5.6% revenue growth. Segment margin of 19.0% significantly exceeds the chemical segment, though declined from prior year's 20.1%. The machinery segment demonstrates superior profitability characteristics with margin 2.5x higher than chemicals. The material margin differential between segments (19.0% vs 7.5%) highlights portfolio diversification benefits while emphasizing the strategic importance of addressing chemical segment profitability challenges to restore consolidated earnings growth.
[Profitability] ROE of 2.6% reflects weak capital efficiency relative to historical performance and peer benchmarks. Operating margin of 10.9% decreased 1.0pt from 11.9% YoY, with net profit margin of 7.2% declining from 8.2%. The modest profitability levels indicate room for improvement in operational efficiency and cost management. [Cash Quality] Cash and deposits of 90.5B yen decreased 43.2B yen (-32.3%) from prior period's 133.7B yen, representing a significant liquidity reduction. Short-term debt coverage stands at 0.85x against current liabilities of 106.3B yen, though current assets of 393.3B yen provide adequate buffer. Trade receivables increased to 150.8B yen from 135.5B yen, while inventories decreased slightly to 65.6B yen from 70.1B yen. [Investment Efficiency] Total asset turnover of 0.282 indicates relatively low asset utilization intensity, characteristic of trading and distribution business models with working capital requirements. [Financial Health] Equity ratio of 77.6% increased from 75.8%, reflecting strong balance sheet structure. Current ratio of 370.1% and equity of 422.5B yen provide substantial financial stability. Net defined benefit asset of 36.2B yen represents pension surplus position.
Cash and deposits decreased 43.2B yen YoY to 90.5B yen, representing a significant 32.3% decline that warrants attention regarding cash deployment activities. Operating profit growth was negative, contributing to cash consumption pressures. Working capital movements show trade receivables increasing 15.3B yen to 150.8B yen, indicating extended collection cycles or revenue growth requiring larger working capital investment. Trade payables decreased 4.4B yen to 41.4B yen, suggesting reduced supplier credit utilization or payment timing effects. Inventories decreased 4.5B yen to 65.6B yen, providing modest working capital relief. The combination of rising receivables and falling payables indicates net working capital expansion that absorbs cash. Treasury stock increased 9.0B yen to 9.0B yen from near-zero prior period, suggesting share repurchase activity that consumed substantial cash. Investment securities increased 3.2B yen to 25.2B yen. Cash coverage of current liabilities stands at 0.85x, with total current assets of 393.3B yen providing 3.7x coverage and maintaining adequate liquidity cushion despite cash balance reduction.
Ordinary income of 16.9B yen versus operating income of 16.7B yen shows non-operating net contribution of approximately 200M yen. This comprises primarily dividend income of 26M yen and miscellaneous non-operating income of 5M yen, partially offset by foreign exchange losses of 9M yen and other non-operating expenses. Non-operating income represents 0.2% of revenue, consisting of stable financial income sources. The minimal gap between operating and ordinary income indicates earnings are predominantly driven by core business operations rather than financial engineering or non-operating items. Comprehensive income of 14.9B yen exceeded net income of 11.1B yen by 3.8B yen, driven by other comprehensive income of 3.8B yen. This included foreign currency translation adjustment of 2.4B yen, valuation difference on securities of 2.2B yen, offset partially by deferred losses on hedges of 0.5B yen and remeasurement losses on defined benefit plans of 0.3B yen. The positive OCI contribution primarily reflects foreign exchange translation gains and unrealized securities gains that enhance equity value but do not represent cash earnings. Without cash flow statement disclosure, direct assessment of operating cash conversion is unavailable, though the significant working capital expansion and receivables growth raise concerns about earnings quality and cash generation capability.
Full-year guidance projects revenue of 632.0B yen (+6.5% YoY), operating income of 57.5B yen (+7.4% YoY), and ordinary income of 57.7B yen (+6.8% YoY). Q1 progress rates are: Revenue 24.3%, Operating Income 29.1%, and Ordinary Income 29.3% of full-year targets. Against standard quarterly progression of 25% for Q1, revenue progress slightly lags while profit progress is ahead of pace, suggesting seasonal factors or management conservatism in full-year projections. Operating income guidance of 57.5B yen implies improvement from Q1's run rate of 16.7B yen per quarter (66.8B yen annualized), indicating expectation of sequential profit recovery in remaining three quarters. The guidance assumes average quarterly operating income of 13.6B yen for remaining Q2-Q4 periods, representing 18.5% decline from Q1 levels. This implies either seasonal patterns with Q1 strength or anticipated headwinds requiring profit recovery actions. No forecast revisions were announced this quarter. Contract liabilities of 11.9B yen on the balance sheet represent advance payments or deferred revenue, providing forward revenue visibility. The backlog-to-quarterly-revenue ratio of 0.78x (11.9B / 15.3B) indicates approximately 2.9 months of forward coverage, suggesting modest pipeline visibility requiring continuous order generation to meet full-year targets.
Annual dividend forecast is 36.00 yen per share for full fiscal year. A note discloses that the company conducted a 3-for-1 stock split effective May 1, 2025, and the stated dividend reflects post-split basis. On a pre-split equivalent basis, the annual dividend would be 108.00 yen. Using the full-year net income forecast and current share count, implied payout ratio would be calculated, but specific quarterly dividend distribution and actual payout percentages are not disclosed in the current period financial statements. The maintained dividend guidance alongside profit decline demonstrates management commitment to shareholder returns, though sustainability depends on working capital improvement and cash flow recovery. Share repurchase activity is evident from treasury stock increasing 9.0B yen to 9.0B yen during the quarter, representing meaningful capital return beyond dividends. This buyback combined with dividends indicates proactive shareholder return policy, though the significant cash consumption (43.2B yen decline in cash) raises questions about optimal capital allocation balance between returns, business investment, and liquidity maintenance.
Segment concentration risk in Chemical Industry Products Sales at 70.6% of revenue exposes consolidated results to market conditions, raw material costs, and competitive dynamics in chemical distribution. The segment's operating profit decline of 12.9% despite flat revenue demonstrates vulnerability to margin pressures. Working capital efficiency risk is evidenced by trade receivables increasing 15.3B yen YoY while revenue grew only 2.5B yen, indicating collection cycle extension or customer credit terms deterioration. This working capital expansion of 150.8B yen receivables (359 days outstanding equivalent) against quarterly revenue of 153.3B yen represents approximately 3.5x quarterly sales in receivables, signaling potential cash conversion challenges. Liquidity risk warrants monitoring as cash decreased 32.3% to 90.5B yen with coverage ratio of current liabilities declining to 0.85x, requiring careful cash management despite overall strong current ratio. The substantial treasury stock purchase of 9.0B yen consuming limited cash raises questions about capital allocation priorities versus business investment needs.
[Industry Position] (Reference - Proprietary Analysis) The company's operating margin of 10.9% exceeds the manufacturing industry median of 6.8% (IQR: 2.9%-9.0%), indicating above-average operational efficiency despite recent margin compression. Net profit margin of 7.2% also surpasses the industry median of 5.9% (IQR: 3.3%-7.7%), reflecting solid bottom-line conversion. However, ROE of 2.6% falls below the industry median of 3.1% (IQR: 2.0%-4.9%), suggesting underutilization of equity capital relative to peers. The equity ratio of 77.6% significantly exceeds the industry median of 43.9% (IQR: 28.4%-50.7%), indicating conservative capital structure with substantial financial stability buffer but potentially suboptimal leverage. Revenue growth of 1.6% lags the industry median of 13.2% (IQR: 2.5%-28.5%), positioning the company in the lower quartile for top-line expansion. Asset turnover of 0.282 exceeds the industry median of 0.17 (IQR: 0.16-0.23), demonstrating relatively efficient asset utilization. The company's current ratio of 370.1% substantially outperforms the industry median of 1.87x, reflecting superior short-term liquidity management. Return on invested capital metrics align with industry characteristics. Overall, the company demonstrates financial stability strengths (high equity ratio, strong liquidity) and profitability margins above industry norms, but faces growth momentum and capital efficiency challenges relative to manufacturing sector peers.
※ Industry: Manufacturing (8 companies), Comparison: 2025-Q1 period, Source: Proprietary analysis
The Chemical Industry Products Sales segment profitability deterioration (-12.9% operating income on flat revenue) represents the primary concern requiring operational turnaround to restore consolidated earnings momentum. Management must address cost structure and pricing strategy in this core 70.6% revenue contributor. Working capital management requires immediate attention, with trade receivables expanding 15.3B yen YoY significantly faster than revenue growth of 2.5B yen, indicating collection efficiency deterioration that impairs cash generation. The 43.2B yen cash decline coupled with 9.0B yen treasury stock purchase highlights capital allocation questions regarding balance between shareholder returns and business liquidity needs. Despite near-term profit pressure, the company maintains structural advantages including operating margins exceeding industry median, ultra-strong balance sheet with 77.6% equity ratio, and superior liquidity with 370% current ratio providing defensive characteristics and capacity to weather cyclical headwinds while executing recovery initiatives.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.